SAN FRANCISCO, April 22 (UPI) -- The drug Avastin fell short in a clinical trial of its goal to reduce the recurrence of early-stage colon cancer, U.S. drug maker Genentech says.
SILVER SPRING, Md., March 31 (UPI) -- A U.S. Food and Drug Administration committee is recommending accelerated approval of the drug Avastin for treating brain cancer.
BASEL, Switzerland, July 21 (UPI) -- Swiss drugmaker Roche Holding AG has offered $43.7 billion -- $89 a share -- for the U.S. biotech firm Genentech.
SAN FRANCISCO, Feb. 22 (UPI) -- The U.S. Food and Drug Administration has granted accelerated approval for Avastin in combination with paclitaxel chemotherapy for treatment of breast cancer.
CHICAGO, June 4 (UPI) -- U.S. firm Genentech said Monday data from two phase 3 trials show the breast cancer drug Herceptin ups survival 52 percent in HER2-positive cases.
LOS ALTOS, Calif., Jan. 9 (UPI) -- U.S. firm Amphora Discovery Corporation said Tuesday Genentech agreed to purchase its oncology program for an undisclosed sum.
SOUTH SAN FRANCISCO, Calif., Nov. 10 (UPI) -- Genentech Inc. has agreed to buy Houston's Tanox Inc., maker of a successful asthma medicine, in an all-cash U.S. deal worth $919 million.
SOUTH SAN FRANCISO, Calif., Feb. 13 (UPI) -- Genentech said Monday it has suspended patient enrollment in the phase 3 study of its colon cancer drug Avastin.
NEW YORK, Sept. 29 (UPI) -- Genentech, Inc., a biotech company in apparent danger of having a key U.S. patent withdrawn remains well-regarded by Wall Street.
SAN FRANCISCO, July 10 (UPI) --
